177 related articles for article (PubMed ID: 25733811)
1. Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents.
Venugopala KN; Govender R; Khedr MA; Venugopala R; Aldhubiab BE; Harsha S; Odhav B
Drug Des Devel Ther; 2015; 9():911-21. PubMed ID: 25733811
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents.
Rahmouni A; Souiei S; Belkacem MA; Romdhane A; Bouajila J; Ben Jannet H
Bioorg Chem; 2016 Jun; 66():160-8. PubMed ID: 27179178
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine.
Filali I; Belkacem MA; Ben Nejma A; Souchard JP; Ben Jannet H; Bouajila J
J Enzyme Inhib Med Chem; 2016; 31(sup1):23-33. PubMed ID: 27028352
[TBL] [Abstract][Full Text] [Related]
4. Novel heterocyclic-fused pyrimidine derivatives: synthesis, molecular modeling and pharmacological screening.
Arafa RK; Nour MS; El-Sayed NA
Eur J Med Chem; 2013 Nov; 69():498-507. PubMed ID: 24090920
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Biological Evaluation of Some 5-Arylthieno[2,3-d]pyrimidines as Potential Anti-cancer Agents.
El-Ansary AK; Kamal AM; Al-Ghorafi MA
Chem Pharm Bull (Tokyo); 2016; 64(8):1172-80. PubMed ID: 27477657
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities.
Filali I; Bouajila J; Znati M; Bousejra-El Garah F; Ben Jannet H
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):371-6. PubMed ID: 25068731
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives.
Barakat A; Islam MS; Al-Majid AM; Ghabbour HA; Fun HK; Javed K; Imad R; Yousuf S; Choudhary MI; Wadood A
Bioorg Med Chem; 2015 Oct; 23(20):6740-8. PubMed ID: 26381063
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives.
Cai J; Zhang S; Zheng M; Wu X; Chen J; Ji M
Bioorg Med Chem Lett; 2012 Jan; 22(2):806-10. PubMed ID: 22217877
[TBL] [Abstract][Full Text] [Related]
9. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
Banti CN; Kyros L; Geromichalos GD; Kourkoumelis N; Kubicki M; Hadjikakou SK
Eur J Med Chem; 2014 Apr; 77():388-99. PubMed ID: 24681027
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of Substituted Pyrimidines as Potential Phosphatidylinositol 3-Kinase (PI3K) Inhibitors.
Zhang JQ; Luo YJ; Xiong YS; Yu Y; Tu ZC; Long ZJ; Lai XJ; Chen HX; Luo Y; Weng J; Lu G
J Med Chem; 2016 Aug; 59(15):7268-74. PubMed ID: 27427973
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
12. Design and optimization of hybrid of 2,4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents.
Zhou W; Huang A; Zhang Y; Lin Q; Guo W; You Z; Yi Z; Liu M; Chen Y
Eur J Med Chem; 2015; 96():269-80. PubMed ID: 25899332
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro.
Shi HB; Li HB; Lu KQ; Zhu XR; Hu WX; Pei W
Arch Pharm (Weinheim); 2011 Oct; 344(10):675-83. PubMed ID: 21984017
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular properties, anti-inflammatory and anticancer activities of novel 3-hydroxyflavone derivatives.
Znati M; Bordes C; Forquet V; Lantéri P; Ben Jannet H; Bouajila J
Bioorg Chem; 2019 Aug; 89():103009. PubMed ID: 31158579
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Hybrids of Dihydropyrimidine and Pyridazinone as potential Anti-Breast Cancer Agents.
Akhtar W; Verma G; Khan MF; Shaquiquzzaman M; Rana A; Anwer T; Akhter M; Alam MM
Mini Rev Med Chem; 2018; 18(4):369-379. PubMed ID: 28486908
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and molecular docking study of new monastrol analogues as kinesin spindle protein inhibitors.
El-Hamamsy MH; Sharafeldin NA; El-Moselhy TF; Tawfik HO
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000060. PubMed ID: 32452567
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure-activity relationship and biological evaluation of 2,4,5-trisubstituted pyrimidine CDK inhibitors as potential anti-tumour agents.
Shao H; Shi S; Foley DW; Lam F; Abbas AY; Liu X; Huang S; Jiang X; Baharin N; Fischer PM; Wang S
Eur J Med Chem; 2013; 70():447-55. PubMed ID: 24185375
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
Kassab AE; Gedawy EM
Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety.
Ragab FAF; Abou-Seri SM; Abdel-Aziz SA; Alfayomy AM; Aboelmagd M
Eur J Med Chem; 2017 Sep; 138():140-151. PubMed ID: 28667871
[TBL] [Abstract][Full Text] [Related]
20. Exploring phenylcarbamoylazinane-1,2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies.
Shahid W; Ashraf M; Saleem M; Bashir B; Muzaffar S; Ali M; Kaleem A; Aziz-Ur-Rehman ; Amjad H; Bhattarai K; Riaz N
Bioorg Chem; 2021 Oct; 115():105261. PubMed ID: 34416506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
